Preceding studies from this laboratory have defined certain changes in body fluids in dogs (1) and, in preliminary form, in human subjects (2, 3) accompanying the ingestion of carboxylic cation exchangers in the hydrogen cycle. In general, hyperchloremia appeared in both groups, the serum bicarbonate was lowered, and the stool output of sodium and potassium increased whereas chloride and nitrogen excretion did not change. In this paper further studies of the resins in various forms in human subjects are reported as a basis for a more adequate understanding of factors contributing to or limiting the clinical utility of these compounds.
MATERIALS AND METHODS
Carboxylic cation exchangers in the hydrogen, ammonium, potassium, sodium, or calcium form have been tested in children and adults with a variety of diseases. Selection of the patients was based primarily on willingness and ability to cooperate in the study. Edema was present in some. The experimental procedures, analytical techniques, and statistical treatment have been detailed in the animal studies mentioned earlier (1) . The patients were usually but not invariably maintained on a milk formula or on a diet not rigidly restricted as to sodium content. Again it should be emphasized that all stools included in the study were formed.
RESULTS
A. Effects of hydrogen or ammonium cycle resin ingestion From Tables I and II and the summary of mean changes in Figure 1 , it is evident that the alterations in serum constituents accompanying comparable average daily intakes of these two agents, 39.7 and 38.3 g. respectively, are essentially indistinguishable. Hyperchloremia, and lowered serum bicarbonate and potassium values developed in both groups of subjects without a statistically significant change in serum sodium. Other measured constituents of serum or blood were not affected. The mean output of sodium and of potassium per day, per unit of stool mass, and per gram of stool nitrogen (Tables III, IV , and Figure 2 ) rose without alteration in the excretion of chloride or nitrogen via this route.
Ingestion of the hydrogen form resin was accompanied by an increase in the average daily urine volumes without statistically significant variation in the total daily output of the various urinary constituents (Table V) . In general the external balances of chloride and of sodium (Table VI) remained positive during resin therapy except in those periods in patients WK, CSc, and GDe, when edema was being delivered and in VG when the body weight was decreasing on a reducing diet. Usually simultaneous declines were recorded in both the chloride space and the extracellular sodium of these subjects. Cell nitrogen balances remained positive during resin therapy save for the obese patient, VG, who was on a limited caloric intake. With but few exceptions losses of potassium from cells coincided with and were induced by hydrogen form resin therapy. The most striking losses occurred in CSc. In the experiments with the ammonium form of the resin it is to be noted that cell potassium balances remained positive during resin therapy (Table VII) . Since the stool excretion of this element had increased significantly it is obvious that the intake of this electrolyte had been more than adequate to prevent negative balances.
It is to be noted in addition that in patient SB who received cortisone as well as the ammonium form of the resin a decrease in serum carbon dioxide content and abnormally low serum potassium concentrations occurred (Table II) together with 995 marked increases in stool sodium and potassium phorus rose slightly when the potassium form of excretion (Table IV and Figure 2 ). the resin was ingested (Figure 1 , Tables VIII and   IX) . On the other hand in subjects CSt and CSc B. Changes during sodium or potassium cycle (Table IX) Figure 2) . Similarly, on an intake of the (Tables XII and XIII ). In the case of the sodium potassium cycle resin, stool potassium and, to a resin, the absorbed cation, sodium, remained prilesser extent, stool sodium increased (Table XI marily in the extracellular phase (Subjects EB, and Figure 2 ). In each group of experiments, JV, and VB). Potassium released from the resin some of the cation, either sodium or potassium, in-on the other hand was retained in the body and gested with the resin was released and entered the entered the cellular phase in patient RC (Table  body fluids. Though daily urinary excretions of XIII). Patients WG and CSc, however, excreted this cation in both urine and stool and lost it from cells.
C. Studies during calcium cycle resin
Insofar as can be determined by inspection of Table XIV 
SERUM ELECTROLYTE CONCENTRATIONS WITH AND WITHOUT RESIN THERAPY
The blocks represent mean alterations in serum constituents between the onset and the end of each of the regimens indicated at the head of the individual columns. The chemical abbreviations stand for the form of resin ingested. Asterisks identify statistically significant differences from the changes in the control values ("p" for the "t" test equals 0.05 or less). Without resin therapy serum constituents listed on the left varied but little. Treatment with H or NHI forms produced acidosis and hyperchloremia and lowered serum potassium levels. Ingestion of the Na form did not produce any significant changes. Serum inorganic phosphorus rose during administration of the K cycle, and serum chloride fell when the Ca form was ingested. in the experiments in which sodium was not rigidly withheld. The few studies in which the diet was almost completely free of sodium are included in the tables, but excluded from the means, to illustrate the decrease in efficiency of the hydrogen and ammonium forms under such circumstances. For simplicity the calculations are omitted, but the findings can be summarized briefly.
The hydrogen, ammonium, and potassium forms of the resin removed equivalent amounts of sodium plus potassium in stools (1.5, 1.9, and 1.9 meq./g. respectively). Mean stool sodium averaged 0.4 to Several of the studies were conducted in patients with edema. WK in Tables I, III , and VI is of particular interest in this respect because on a combination of marked sodium restriction and resin therapy his body weight dropped 5.6 kg. in nine days. The stool sodium excretion during this interval totaled 88 meq. It is obvious that this de- On the other hand in patient CSc in the same tables much larger amounts of sodium were excreted in stools during the administration of the exchanger together with a milk diet unrestricted as to sodium. It is reasonable to suggest that without resin to interfere with the absorption of the ingested sodium this patient would not have lost edema fluid. Patient GDe demonstrates the degree to which the efficacy of the resin in augmenting stool sodium can vary not only from patient to patient, but also in the same subject. In the 10 to 15 day period he lost much less sodium per day in stool than in the somewhat longer 19 to 25 day interval. In this patient it is again worth pointing out that his initial huge diuresis with a body weight loss of 9.9 kg. cannot be attributed to stool losses of sodium, but that the marked acidosis which appeared during resin therapy may have hastened the delivery of the edema fluid.
Finally it should be pointed out that these exchangers have been administered to patients with renal failure. These can be most readily identified by the elevated blood nonprotein nitrogen values in the various tables of serum and blood data. The fact that in this series no complications developed such as clinical acidosis or potassium intoxication does not mean that these exchangers can be used with impunity in all forms of renal disease. The risks and benefits have been described in greater detail in another paper in this series (5) . Insofar as the current studies are concerned it should be emphasized that they were of limited duration and interrupted short of undesirable or dangerous changes when certain trends had become well established, as with the acidosis in GDe, Table  I . Incidentally, the ammonium released from the ammonium form of the resin apparently does not raise whole blood nonprotein nitrogen, but it may have, in some patients, as in WG, Table IV, raised the output of nitrogen in urine.
DISCUSSION
The data which have been presented indicate that the hydrogen and the ammonium forms of the resin produce effects which are indistinguishable, including essentially equal tendencies to induce acidosis and to increase the excretion of sodium and potassium in the stool. Furthermore, neither influences the output of nitrogen and chloride via this route. Although the efficiency of these resins is relatively low in uivo, it is clear that they may be useful in reducing the absorption of sodium from the diet so that a patient requiring low sodium therapy could ingest food seasoned with more of this cation. That he could not ingest much larger amounts of salt should be clear from the data indicating that each gram of the hydrogen or ammonium forms will remove only up to 1 meq. of sodium.
These studies also support an interpretation voiced elsewhere (1), i.e., that the acidifying resins produce certain serum effects similar to those which follow the use of diuretics such as ammonium chloride, potassium nitrate, et cetera. This suggests that the diuresis accompanying hydrogen or ammonium cycle resin therapy of patients cannot be augmented by the use of acidifying diuretics. On the other hand it is reasonable to predict that mercurial diuretics used in conjunction with these two acidifying resins will exert their maximal effects without the aid of ammonium chloride. There is, however, probably an increased danger of producing potassium depletion under these circumstances which may be counteracted by administration of extra potassium.
Certain extrapolations seem justified with respect to possible clinical application of the sodium and potassium cycle resin findings. The relatively high efficiency of the sodium cycle resin in augmenting the stool output of potassium suggests its possible application in renal insufficiency of the salt-wastage and potassium accumulation type. This agent under such circumstances should augment the external losses of potassium and simultaneously cancel the negative balances of sodium which characterize this disorder (6) (7) (8) .
The effects of the potassium cycle exchanger suggest that it may be beneficially employed in combination with the hydrogen or ammonium cycle congeners. It is obvious that upon exchange with sodium and hydrogen present in the intestinal tract the released potassium becomes available for absorption and is, as the data indicate, in great measure retained. This effect should serve to cancel
